Here, we report that targeting of LDHC in breast cancer cells has the potential to tip the fine balance between tolerable and excessive levels of genomic damage in favor of the latter and as such to sensitize cancer cells to DNA damage inducers and DNA damage repair inhibitors (Fig. 7). This evidence concerns the gene LDHC and breast carcinoma.